Bone Cancer Trial Results
- Radium-223 Improves Survival in Patients with Advanced Prostate Cancer
(Posted: 08/02/2013) - Results from a phase III trial show that radium-223 dichloride (Xofigo®) improves overall survival in men with advanced prostate cancer that has spread to their bones compared with placebo.
- Experimental Drug for Osteosarcoma Improves Overall Survival
(Posted: 03/04/2008) - Patients with osteosarcoma who received the experimental drug mifamurtide (L-MTP-PE) along with chemotherapy fared better than patients who received chemotherapy alone, according to the Feb. 1, 2008, Journal of Clinical Oncology.